TITLE

Exposure to SSRI Antidepressants In Utero Causes Birth Defects, Neonatal Withdrawal Symptoms, and Brain Damage

AUTHOR(S)
Breggin, Peter R.; Breggin, Ginger
PUB. DATE
March 2008
SOURCE
Ethical Human Psychology & Psychiatry;2008, Vol. 10 Issue 1, p5
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Pregnant mothers should avoid taking SSRI antidepressants--they are hazardous to the developing fetus, cause withdrawal symptoms in the newborn baby, and induce biochemical and morphological abnormalities in the brain. If pregnant mothers need help with sad or anxious feelings, they should seek counseling or psychotherapy, especially family therapy involving the child's father, as well as other sources of emotional support.
ACCESSION #
33294565

 

Related Articles

  • Encourage depression screening for all pregnant women. Edlin, Mari // Managed Healthcare Executive;Nov2009, Vol. 19 Issue 11, p21 

    The article offers information on depression in pregnant women. It notes that according to the American Psychiatric Association (APA) and the American College of Obstetrics and Gynecologists (ACOG), prevalence of expectant moms that experience depressive symptoms is between 14 and 23 percent. It...

  • Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and... Einarson, Adrienne; Selby, Peter; Koren, Gideon // Journal of Psychiatry & Neuroscience;Jan2001, Vol. 26 Issue 1, p44 

    Assesses the consequences to mother and baby of abruptly discontinuing antidepressant or benzodiazepine medication during pregnancy and, assesses the impact of counseling. Risks and benefits of taking psychotropic medication during pregnancy; Consideration of serious adverse effects; Importance...

  • Ask Dr Rosie.  // Woman's Day (Australia Edition);1/30/2006, Vol. 58 Issue 5, p58 

    The article offers advice related to interpersonal relationships. An unwed pregnant woman asks how she would tell her conservative mother about her condition. Another questions the effects of antidepressants on orgasm.

  • In utero SSRI exposure: Health Canada warns of risks to neonates.  // Reactions Weekly;3/18/2006, Issue 1093, p3 

    Reports the warning issued by Health Canada against the use of selective serotonin reuptake inhibitors (SSRI), a group of antidepressants, during pregnancy as of March 2006. Neonatal complications associated with using SSRI during the second half of pregnancy; Advice of Health Canada to pregnant...

  • ask the expert. Livoti, Carol // Shape;Aug2006, Vol. 25 Issue 12, p90 

    The article presents a question and the answer related to pregnancy and anti-depressant medication. A reader asks whether she should stop taking her anti-depressant medication. The reader is advised to consult her doctor before she does so. Anti-depressants are considered safe if it is used...

  • Psychotherapy for Pregnant Women with Schizophrenia. Miller, Laura J. // Current Women's Health Reviews;2010, Vol. 6 Issue 1, p39 

    For some women with schizophrenia, adapting emotionally to pregnancy and motherhood is a struggle. Women with schizophrenia may have difficulty acknowledging and accepting the pregnant state, accurately interpreting the physical changes brought on by pregnancy, accepting prenatal care, managing...

  • Exposure to SSRI Antidepressants in Pregnancy. Mintzes, Barbara; Jureidini, Jon // Women & Environments International Magazine;Spring2009, Issue 78/79, p29 

    The article discusses the benefits of selective serotonin release inhibitor (SSRI) antidepressants in pregnancy. Particular focus is given to determining the net benefit using SSRI during pregnancy for the treatment of a mother's depression, and the net benefit or net harm of SSRI use to...

  • Birth Outcomes in Pregnant Women Taking Fluoxetine. Cohen, Lee S.; Rosenbaum, Jerrold F. // New England Journal of Medicine;3/20/97, Vol. 336 Issue 12, p872 

    A letter to the editor is presented in response to the article "Birth Outcomes in Pregnant Women Taking Fluoxetine," which was published in the October 3, 1996 issue.

  • Birth Outcomes in Pregnant Women Taking Fluoxetine. Goldstein, David J.; Sundell, Karen L.; Corbin, Lois A. // New England Journal of Medicine;3/20/97, Vol. 336 Issue 12, p872 

    A letter to the editor is presented in response to the article "Birth Outcomes in Pregnant Women Taking Fluoxetine," which was published in the October 3, 1996 issue.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics